title: Cardiac xenotransplantation technology provides materials for improved bioprosthetic heart valves.
authors.forename: Rizwan A
authors.initials: RA
authors.lastname: Manji
authors.forename: Alan H
authors.initials: AH
authors.lastname: Menkis
authors.forename: David K C
authors.initials: DK
authors.lastname: Cooper
mesh_terms: D000818:Animals; D030801:Animals, Genetically Modified; D000906:Antibodies / Q000097:blood; D001705:Bioprosthesis; D005700:Galactosyltransferases / Q000172:deficiency / Q000235:genetics / Q000276:immunology; D006084:Graft Rejection / Q000276:immunology / Q000517:prevention & control; D006085:Graft Survival; D006350:Heart Valve Prosthesis; D019918:Heart Valve Prosthesis Implantation / Q000295:instrumentation*; D006351:Heart Valves / Q000276:immunology / Q000637:transplantation*; D006801:Humans; D011474:Prosthesis Design; D013552:Swine; D023001:Transplantation Tolerance / Q000235:genetics; D014183:Transplantation, Heterologous; D016896:Treatment Outcome
chemical_list: D000906:Antibodies; D005700:Galactosyltransferases; C530267:alpha-1,3-galactosyltransferase 1, porcine